Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelheim d…
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent expiration for Glaxosmithkline drug …
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Gla…
New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Glaxosmithkline drug ARN…
New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared firs…
New patent expiration for Mylan Speciality drug ELESTRIN Read Post »
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 6,537,983 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations for t…
Drug Patent Expirations for the Week of August 1, 2021 Read Post »
This chart shows the drugs with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Sloven…
Which pharmaceutical drugs have the most drug patents in Slovenia? Read Post »
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
The post Drugs facing the most…
Drugs facing the most patent expirations this year Read Post »
Get new actionable insights and updates from BiotechBlog
